AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel
- AstraZeneca launches its digital health program- BeyondBio with the initial investment of $2.8M
- AstraZeneca in collaborates with JVP to support Israeli start-up companies by providing direct access to databases and leading academic research institutes in digital health with an aim to find technological solutions in the medical sphere
- The digital health program is operated in collaboration with JVP- the Israel National Initiative Association- Maccabitech Healthcare Research and Innovation Institute and Microsoft. Additionally- AstraZeneca team up with ARC Innovation Center top provide support in research and development targeting challenges in the health care system in Israel
Click here to read full press release/ article
Ref: JVP | Image: AstraZeneca
Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at [email protected].